QUETIAPINE FUMARATE

QUETIAPINE FUMARATE was reported 30130 times

These side effects are most commonly reported by patients taking QUETIAPINE FUMARATE:

# Side effect Count
0 DRUG INEFFECTIVE 3826
1 OFF LABEL USE 3330
2 FATIGUE 2819
3 PAIN 2811
4 CONDITION AGGRAVATED 2242
5 HEADACHE 2204
6 TOXICITY TO VARIOUS AGENTS 2192
7 RHEUMATOID ARTHRITIS 2189
8 NAUSEA 2169
9 RASH 2153
10 WEIGHT INCREASED 2143
11 VOMITING 2122
12 HYPERTENSION 1971
13 PEMPHIGUS 1913
14 PYREXIA 1906
15 DIZZINESS 1896
16 DRUG INTERACTION 1876
17 ABDOMINAL DISCOMFORT 1861
18 DEPRESSION 1860
19 PRODUCT USE ISSUE 1858
20 ALOPECIA 1800
21 SYSTEMIC LUPUS ERYTHEMATOSUS 1800
22 HEPATIC ENZYME INCREASED 1793
23 PSORIATIC ARTHROPATHY 1790
24 DIARRHOEA 1779
25 CONFUSIONAL STATE 1778
26 JOINT SWELLING 1772
27 GLOSSODYNIA 1752
28 WOUND 1743
29 INFUSION RELATED REACTION 1716
30 LIVER INJURY 1705
31 MATERNAL EXPOSURE DURING PREGNANCY 1676
32 ARTHRALGIA 1645
33 PNEUMONIA 1645
34 HYPERSENSITIVITY 1596
35 PERICARDITIS 1579
36 COMPLETED SUICIDE 1573
37 DRUG INTOLERANCE 1560
38 DYSPNOEA 1557
39 ARTHROPATHY 1550
40 GENERAL PHYSICAL HEALTH DETERIORATION 1547
41 ANXIETY 1518
42 HAND DEFORMITY 1498
43 PRODUCT USE IN UNAPPROVED INDICATION 1488
44 SWELLING 1481
45 CONTRAINDICATED PRODUCT ADMINISTERED 1465
46 NASOPHARYNGITIS 1458
47 PRESCRIBED OVERDOSE 1433
48 TYPE 2 DIABETES MELLITUS 1421
49 SYNOVITIS 1418
50 MUSCULOSKELETAL STIFFNESS 1411
51 EXPOSURE DURING PREGNANCY 1399
52 OVERDOSE 1397
53 WHEEZING 1383
54 PERIPHERAL SWELLING 1354
55 SUICIDE ATTEMPT 1336
56 DECREASED APPETITE 1333
57 DISCOMFORT 1325
58 MALAISE 1325
59 INFECTION 1323
60 HYPOAESTHESIA 1314
61 HELICOBACTER INFECTION 1307
62 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1305
63 URTICARIA 1294
64 ASTHENIA 1293
65 BLOOD CHOLESTEROL INCREASED 1276
66 DRUG HYPERSENSITIVITY 1272
67 PRURITUS 1252
68 DUODENAL ULCER PERFORATION 1247
69 IRRITABLE BOWEL SYNDROME 1209
70 FIBROMYALGIA 1205
71 BLISTER 1203
72 ABDOMINAL PAIN UPPER 1201
73 ASTHMA 1191
74 IMPAIRED HEALING 1191
75 INTENTIONAL PRODUCT USE ISSUE 1180
76 INSOMNIA 1168
77 MOBILITY DECREASED 1163
78 MEMORY IMPAIRMENT 1157
79 TREATMENT FAILURE 1157
80 STOMATITIS 1154
81 MUSCLE INJURY 1151
82 LOWER RESPIRATORY TRACT INFECTION 1149
83 SOMNOLENCE 1149
84 OEDEMA 1141
85 FOLLICULITIS 1089
86 RHEUMATOID FACTOR POSITIVE 1071
87 JOINT RANGE OF MOTION DECREASED 1068
88 INJURY 1067
89 OSTEOARTHRITIS 1049
90 PAIN IN EXTREMITY 1044
91 RHEUMATIC FEVER 1043
92 CONTUSION 1032
93 OEDEMA PERIPHERAL 1013
94 CHEST PAIN 1009
95 WEIGHT DECREASED 968
96 DRUG ABUSE 951
97 PULMONARY FIBROSIS 947
98 SINUSITIS 939
99 FALL 931
100 SLEEP DISORDER 920
101 GAIT DISTURBANCE 909
102 SEDATION 905
103 DELIRIUM 880
104 MUSCLE SPASMS 880
105 BURSITIS 875
106 PSORIASIS 870
107 OBESITY 868
108 PARAESTHESIA 864
109 HYPOTENSION 862
110 DRY MOUTH 856
111 WOUND INFECTION 856
112 INTENTIONAL OVERDOSE 843
113 DEATH 832
114 LOWER LIMB FRACTURE 831
115 SWOLLEN JOINT COUNT INCREASED 816
116 GAIT INABILITY 815
117 MUSCULOSKELETAL PAIN 812
118 THERAPEUTIC PRODUCT EFFECT DECREASED 812
119 ABDOMINAL PAIN 810
120 ROAD TRAFFIC ACCIDENT 805
121 DYSPEPSIA 790
122 MIGRAINE 769
123 SUICIDAL IDEATION 769
124 LUNG DISORDER 765
125 HYPERCHOLESTEROLAEMIA 760
126 NIGHT SWEATS 755
127 PRESCRIBED UNDERDOSE 748
128 TREMOR 728
129 HYPERHIDROSIS 725
130 CONSTIPATION 724
131 TACHYCARDIA 717
132 LIP DRY 716
133 DYSKINESIA 714
134 ADVERSE DRUG REACTION 702
135 GASTROINTESTINAL DISORDER 702
136 UPPER RESPIRATORY TRACT INFECTION 699
137 AMNESIA 687
138 PERIPHERAL VENOUS DISEASE 671
139 THERAPY NON-RESPONDER 665
140 DEEP VEIN THROMBOSIS POSTOPERATIVE 660
141 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 660
142 AUTOIMMUNE DISORDER 655
143 SCIATICA 643
144 ILL-DEFINED DISORDER 637
145 INFLAMMATION 637
146 C-REACTIVE PROTEIN INCREASED 628
147 BREAST CANCER STAGE III 625
148 INTENTIONAL PRODUCT MISUSE 623
149 DYSTONIA 617
150 VISUAL IMPAIRMENT 581
151 MUSCULAR WEAKNESS 580
152 C-REACTIVE PROTEIN ABNORMAL 576
153 FLUID RETENTION 570
154 LIVER DISORDER 562
155 DISLOCATION OF VERTEBRA 559
156 AGITATION 556
157 LOSS OF CONSCIOUSNESS 556
158 LUPUS VULGARIS 548
159 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 544
160 OSTEOPOROSIS 540
161 ADVERSE EVENT 538
162 HALLUCINATION 538
163 FACET JOINT SYNDROME 536
164 SCHIZOPHRENIA 530
165 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 523
166 THROMBOCYTOPENIA 523
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 518
168 PSYCHOTIC DISORDER 514
169 ELECTROCARDIOGRAM QT PROLONGED 511
170 GRIP STRENGTH DECREASED 499
171 GASTROOESOPHAGEAL REFLUX DISEASE 489
172 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 484
173 COMA 483
174 BLOOD GLUCOSE INCREASED 481
175 RETINITIS 473
176 SEXUAL DYSFUNCTION 472
177 LIVE BIRTH 464
178 NEUROLEPTIC MALIGNANT SYNDROME 463
179 DEPRESSED LEVEL OF CONSCIOUSNESS 462
180 IMMUNODEFICIENCY 452
181 HIP ARTHROPLASTY 451
182 METABOLIC DISORDER 447
183 BACK PAIN 444
184 RED BLOOD CELL SEDIMENTATION RATE INCREASED 441
185 COUGH 440
186 SOPOR 440
187 CROHN^S DISEASE 430
188 BLOOD PROLACTIN ABNORMAL 427
189 ARTHRITIS 425
190 JOINT STIFFNESS 420
191 LUPUS-LIKE SYNDROME 416
192 KNEE ARTHROPLASTY 415
193 HEPATIC CIRRHOSIS 413
194 CARDIAC ARREST 394
195 PRODUCT DOSE OMISSION ISSUE 394
196 JOINT DISLOCATION 388
197 EPILEPSY 386
198 LEUKOPENIA 385
199 LARYNGITIS 384
200 EXOSTOSIS 382
201 FOOD ALLERGY 378
202 SEIZURE 375
203 ANOSOGNOSIA 374
204 PERSONALITY CHANGE 374
205 SEROTONIN SYNDROME 372
206 PRODUCT QUALITY ISSUE 371
207 DISTURBANCE IN SOCIAL BEHAVIOUR 368
208 MEDICATION ERROR 368
209 EAR INFECTION 367
210 FOETAL EXPOSURE DURING PREGNANCY 366
211 RASH ERYTHEMATOUS 364
212 ACUTE KIDNEY INJURY 363
213 FOOT DEFORMITY 359
214 ERYTHEMA 358
215 AGGRESSION 354
216 X-RAY ABNORMAL 349
217 LIVER FUNCTION TEST INCREASED 344
218 TASTE DISORDER 341
219 AKATHISIA 339
220 BLOOD PRESSURE INCREASED 339
221 URINARY TRACT INFECTION 329
222 FEELING ABNORMAL 326
223 BONE EROSION 324
224 NEUTROPENIA 317
225 PANCREATITIS 317
226 BRONCHITIS 316
227 BLEPHAROSPASM 315
228 CARDIO-RESPIRATORY ARREST 313
229 FOETAL DEATH 313
230 TREATMENT NONCOMPLIANCE 309
231 THERAPEUTIC RESPONSE DECREASED 303
232 INTENTIONAL SELF-INJURY 295
233 ANAEMIA 288
234 UNDERDOSE 285
235 WALKING AID USER 282
236 ABNORMAL BEHAVIOUR 281
237 DIABETES MELLITUS 281
238 DRUG-INDUCED LIVER INJURY 278
239 DISABILITY 277
240 NAIL DISORDER 275
241 RESTLESSNESS 272
242 FEELING HOT 269
243 TEMPERATURE REGULATION DISORDER 269
244 BREAST CANCER STAGE II 264
245 BLOOD CREATINE PHOSPHOKINASE INCREASED 260
246 HOSPITALISATION 259
247 PARANOIA 258
248 WHITE BLOOD CELL COUNT INCREASED 257
249 RHABDOMYOLYSIS 256
250 EXTRAPYRAMIDAL DISORDER 255
251 SPEECH DISORDER 254
252 PARKINSONISM 252
253 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 249
254 COELIAC DISEASE 249
255 BALANCE DISORDER 248
256 COLITIS ULCERATIVE 245
257 HALLUCINATION, AUDITORY 245
258 COGNITIVE DISORDER 244
259 MANIA 242
260 VISION BLURRED 240
261 PREGNANCY 238
262 RESPIRATORY ARREST 236
263 HALLUCINATION, VISUAL 234
264 DEHYDRATION 232
265 DYSPHAGIA 231
266 FREQUENT BOWEL MOVEMENTS 231
267 HEART RATE INCREASED 229
268 IRRITABILITY 227
269 HYPOKALAEMIA 225
270 HYPONATRAEMIA 224
271 DELUSION 218
272 RECTAL HAEMORRHAGE 218
273 BLOOD CREATININE INCREASED 214
274 ULCER HAEMORRHAGE 213
275 VERTIGO 213
276 CARDIAC FAILURE 212
277 PNEUMONIA ASPIRATION 212
278 BACK DISORDER 210
279 DISTURBANCE IN ATTENTION 210
280 UNRESPONSIVE TO STIMULI 204
281 DRUG TOLERANCE DECREASED 203
282 MENTAL DISORDER 203
283 ALTERED STATE OF CONSCIOUSNESS 202
284 C-REACTIVE PROTEIN 202
285 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 202
286 SYNCOPE 202
287 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 202
288 MYALGIA 200
289 ASPIRATION 199
290 DISORIENTATION 199
291 RESPIRATORY DISORDER 199
292 RENAL FAILURE 198
293 DEPRESSED MOOD 197
294 HYPOXIA 197
295 SERONEGATIVE ARTHRITIS 197
296 TARDIVE DYSKINESIA 197
297 OROPHARYNGEAL PAIN 195
298 OXYGEN SATURATION DECREASED 191
299 PALPITATIONS 191
300 RESPIRATORY FAILURE 190
301 MUSCLE RIGIDITY 187
302 INFLUENZA LIKE ILLNESS 186
303 PORPHYRIA ACUTE 186
304 SINUS TACHYCARDIA 186
305 POISONING DELIBERATE 185
306 HYPOMANIA 184
307 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 183
308 URINARY RETENTION 183
309 OBSESSIVE-COMPULSIVE DISORDER 181
310 RESTLESS LEGS SYNDROME 181
311 STRESS 181
312 CHOLELITHIASIS 179
313 DYSARTHRIA 178
314 WHITE BLOOD CELL COUNT DECREASED 177
315 ALANINE AMINOTRANSFERASE INCREASED 174
316 PLEURAL EFFUSION 173
317 COVID-19 172
318 PUSTULAR PSORIASIS 172
319 HALLUCINATIONS, MIXED 171
320 ILLNESS 170
321 CHRONIC KIDNEY DISEASE 169
322 MYOSITIS 168
323 WITHDRAWAL SYNDROME 168
324 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 165
325 THINKING ABNORMAL 165
326 HYPERSOMNIA 164
327 INFLUENZA 164
328 RASH VESICULAR 164
329 BLOOD PRESSURE DECREASED 159
330 ARRHYTHMIA 158
331 DRUG WITHDRAWAL SYNDROME 158
332 MOOD ALTERED 158
333 RASH PRURITIC 158
334 ACCIDENTAL OVERDOSE 156
335 DRUG DEPENDENCE 156
336 PULMONARY EMBOLISM 155
337 RENAL IMPAIRMENT 155
338 INCREASED APPETITE 154
339 NECK PAIN 154
340 POISONING 154
341 BRADYCARDIA 150
342 MYOCARDITIS 149
343 NIGHTMARE 149
344 PULMONARY OEDEMA 149
345 GENERAL SYMPTOM 148
346 ABDOMINAL DISTENSION 146
347 DRUG TOXICITY 146
348 BRONCHIECTASIS 145
349 EAR PAIN 145
350 STAPHYLOCOCCAL INFECTION 144
351 HAEMOGLOBIN DECREASED 143
352 MENTAL IMPAIRMENT 141
353 HYPOGLYCAEMIA 140
354 LETHARGY 140
355 RESPIRATORY DEPRESSION 140
356 EUPHORIC MOOD 139
357 MENTAL STATUS CHANGES 138
358 PARKINSON^S DISEASE 135
359 NO ADVERSE EVENT 134
360 URINARY INCONTINENCE 134
361 ORTHOSTATIC HYPOTENSION 133
362 BACK INJURY 132
363 BLOOD BILIRUBIN INCREASED 131
364 ANGER 130
365 INCORRECT DOSE ADMINISTERED 130
366 SEPTIC SHOCK 130
367 DRUG LEVEL INCREASED 129
368 HEPATOTOXICITY 128
369 DEMENTIA 127
370 ENCEPHALOPATHY 127
371 SEPSIS 127
372 THERMAL BURN 127
373 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 126
374 HYPERGLYCAEMIA 126
375 PSYCHIATRIC DECOMPENSATION 125
376 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 124
377 INJECTION SITE PAIN 124
378 MYOCARDIAL INFARCTION 124
379 PRODUCTIVE COUGH 124
380 BIPOLAR DISORDER 123
381 EMOTIONAL DISTRESS 122
382 HYPOCHOLESTEROLAEMIA 122
383 OBSTRUCTIVE AIRWAYS DISORDER 122
384 PRIAPISM 121
385 METABOLIC ACIDOSIS 119
386 PSYCHOMOTOR HYPERACTIVITY 119
387 ANTICHOLINERGIC SYNDROME 117
388 DYSLIPIDAEMIA 117
389 PLATELET COUNT DECREASED 116
390 TROPONIN INCREASED 116
391 DEPRESSIVE SYMPTOM 115
392 CHILLS 114
393 APATHY 113
394 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113
395 DISINHIBITION 112
396 BRADYPHRENIA 111
397 LABORATORY TEST ABNORMAL 111
398 CHEST DISCOMFORT 110
399 EYE PAIN 109
400 JAUNDICE CHOLESTATIC 109
401 NASAL CONGESTION 109
402 CEREBROVASCULAR ACCIDENT 108
403 SPONDYLITIS 108
404 APHASIA 107
405 DEPRESSION SUICIDAL 107
406 CATATONIA 106
407 INSURANCE ISSUE 106
408 ABORTION SPONTANEOUS 105
409 HEPATIC FUNCTION ABNORMAL 105
410 TRANSAMINASES INCREASED 105
411 ATRIAL FIBRILLATION 104
412 MYOCLONUS 104
413 PSYCHOMOTOR SKILLS IMPAIRED 104
414 HEAD INJURY 103
415 MOOD SWINGS 103
416 MYDRIASIS 103
417 PANIC ATTACK 103
418 TEARFULNESS 102
419 CONVULSION 101
420 JOINT DESTRUCTION 100
421 DRUG TOLERANCE 99
422 HEART RATE DECREASED 99
423 THERAPEUTIC PRODUCT EFFECT VARIABLE 99
424 ASPARTATE AMINOTRANSFERASE INCREASED 98
425 BODY TEMPERATURE INCREASED 98
426 HAEMOPTYSIS 98
427 INFUSION SITE REACTION 98
428 SUBSTANCE ABUSE 98
429 RALES 97
430 RENAL DISORDER 97
431 BLOOD PRESSURE FLUCTUATION 96
432 EYE INJURY 96
433 MATERNAL EXPOSURE TIMING UNSPECIFIED 96
434 BRADYKINESIA 95
435 BURNING SENSATION 95
436 LIMB DISCOMFORT 94
437 METABOLIC SYNDROME 94
438 WEIGHT FLUCTUATION 94
439 MULTIPLE DRUG OVERDOSE 93
440 SHOCK 93
441 BLOOD PROLACTIN INCREASED 92
442 SALIVARY HYPERSECRETION 92
443 HYPOTHYROIDISM 91
444 BLOOD TEST ABNORMAL 90
445 CARDIAC DISORDER 90
446 CONGENITAL ANOMALY 90
447 MOVEMENT DISORDER 90
448 ADRENAL INSUFFICIENCY 89
449 RETCHING 89
450 PRESYNCOPE 88
451 UNEVALUABLE EVENT 88
452 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 87
453 INFARCTION 87
454 MULTIPLE ORGAN DYSFUNCTION SYNDROME 87
455 NORMAL NEWBORN 87
456 PRODUCT SUBSTITUTION ISSUE 87
457 SWELLING FACE 87
458 BLOOD POTASSIUM INCREASED 86
459 DYSURIA 86
460 ONYCHOMADESIS 86
461 POOR QUALITY SLEEP 86
462 STUBBORNNESS 86
463 BLOOD PRESSURE SYSTOLIC INCREASED 84
464 CRYING 84
465 COMA SCALE ABNORMAL 83
466 HYPERPROLACTINAEMIA 83
467 MUSCLE TWITCHING 83
468 SLEEP APNOEA SYNDROME 83
469 HYPOKINESIA 82
470 INTENTIONAL DRUG MISUSE 82
471 SPUTUM DISCOLOURED 82
472 BRAIN INJURY 81
473 OCULOGYRIC CRISIS 81
474 POLYARTHRITIS 81
475 BLOOD SODIUM DECREASED 80
476 GESTATIONAL DIABETES 80
477 ANGINA PECTORIS 79
478 BLOOD CALCIUM INCREASED 79
479 BLOOD LACTATE DEHYDROGENASE INCREASED 79
480 HEPATITIS 79
481 TORSADE DE POINTES 79
482 DRY SKIN 78
483 HAEMATOCRIT DECREASED 77
484 MIOSIS 77
485 SCHIZOAFFECTIVE DISORDER 77
486 STATUS EPILEPTICUS 77
487 TINNITUS 77
488 TOXIC ENCEPHALOPATHY 77
489 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 76
490 CARDIAC MURMUR 76
491 EMOTIONAL DISORDER 76
492 PALLOR 76
493 DEEP VEIN THROMBOSIS 75
494 GASTROINTESTINAL HAEMORRHAGE 75
495 HYPERREFLEXIA 75
496 LACTIC ACIDOSIS 75
497 LUNG OPACITY 75
498 THERAPY PARTIAL RESPONDER 75
499 ANHEDONIA 74
500 RHINORRHOEA 74
501 TOTAL LUNG CAPACITY DECREASED 74
502 HYPOTHERMIA 73
503 MIDDLE INSOMNIA 73
504 SPINAL FUSION SURGERY 72
505 DECREASED IMMUNE RESPONSIVENESS 71
506 GRIP STRENGTH 71
507 INTESTINAL OBSTRUCTION 71
508 LIMB INJURY 71
509 POSTURE ABNORMAL 71
510 VENTRICULAR FIBRILLATION 71
511 DEATH NEONATAL 70
512 HAEMORRHAGE 70
513 HEPATIC FAILURE 70
514 SEDATION COMPLICATION 70
515 AGRANULOCYTOSIS 69
516 DRUG LEVEL BELOW THERAPEUTIC 69
517 EATING DISORDER 69
518 OVERLAP SYNDROME 69
519 PITUITARY TUMOUR BENIGN 69
520 PULMONARY MASS 69
521 DIABETIC KETOACIDOSIS 68
522 BLOOD TRIGLYCERIDES INCREASED 67
523 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 67
524 LUNG NEOPLASM MALIGNANT 67
525 BEZOAR 66
526 BRAIN OEDEMA 66
527 HYPOCALCAEMIA 66
528 NERVOUSNESS 66
529 POLLAKIURIA 66
530 SWOLLEN TONGUE 66
531 DISEASE RECURRENCE 65
532 GAMMA-GLUTAMYLTRANSFERASE INCREASED 65
533 HEPATIC STEATOSIS 65
534 NEUTROPHIL COUNT DECREASED 65
535 AMENORRHOEA 64
536 CIRCULATORY COLLAPSE 64
537 MAJOR DEPRESSION 64
538 RHINITIS ALLERGIC 64
539 SARCOIDOSIS 64
540 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 63
541 BACTERIAL INFECTION 63
542 DELUSIONAL DISORDER, PERSECUTORY TYPE 63
543 HEPATIC ENZYME 63
544 HYPERTHERMIA 63
545 HYPERTRANSAMINASAEMIA 63
546 NASAL POLYPS 63
547 ORTHOSTATIC HYPERTENSION 63
548 PANCYTOPENIA 63
549 THERAPEUTIC RESPONSE SHORTENED 63
550 TOTAL LUNG CAPACITY INCREASED 63
551 CARDIOMYOPATHY 62
552 ECZEMA 62
553 FAECALOMA 62
554 FEELING COLD 62
555 GASTROENTERITIS VIRAL 62
556 PLEURITIC PAIN 62
557 SKIN DISCOLOURATION 62
558 HYPERKALAEMIA 61
559 NERVOUS SYSTEM DISORDER 61
560 RESPIRATORY TRACT INFECTION 61
561 SWOLLEN JOINT COUNT 61
562 LEUKOCYTOSIS 60
563 PSYCHIATRIC SYMPTOM 60
564 ABNORMAL DREAMS 59
565 AMYLASE INCREASED 59
566 CELLULITIS 59
567 DROOLING 59
568 PRODUCT ADMINISTRATION ERROR 59
569 EYE IRRITATION 58
570 GENERALISED TONIC-CLONIC SEIZURE 58
571 MATERNAL EXPOSURE BEFORE PREGNANCY 58
572 SOMNAMBULISM 58
573 THIRST 58
574 COGWHEEL RIGIDITY 57
575 DYSPNOEA EXERTIONAL 57
576 DYSSTASIA 57
577 GROWTH HORMONE DEFICIENCY 57
578 NEUROPATHY PERIPHERAL 57
579 PERSECUTORY DELUSION 57
580 PSYCHOMOTOR RETARDATION 57
581 SKIN EXFOLIATION 57
582 VENTRICULAR DYSFUNCTION 57
583 ACUTE RESPIRATORY DISTRESS SYNDROME 56
584 CARDIAC FAILURE CONGESTIVE 56
585 CYANOSIS 56
586 DISSOCIATION 56
587 EPISTAXIS 56
588 FEEDING DISORDER 56
589 FLANK PAIN 56
590 FLUSHING 56
591 FUNGAL INFECTION 56
592 HEPATIC CYTOLYSIS 56
593 MYOGLOBIN URINE PRESENT 56
594 NODULE 56
595 THROMBOSIS 56
596 CYSTITIS 55
597 DRUG DOSE OMISSION 55
598 EMOTIONAL POVERTY 55
599 GALACTORRHOEA 55
600 HYPOPHAGIA 55
601 LIBIDO DECREASED 55
602 PLATELET COUNT INCREASED 55
603 PRODUCT PRESCRIBING ISSUE 55
604 THERAPEUTIC RESPONSE UNEXPECTED 55
605 AFFECTIVE DISORDER 54
606 BLOOD PRESSURE SYSTOLIC ABNORMAL 54
607 FEELING JITTERY 54
608 HIP FRACTURE 54
609 INCONTINENCE 54
610 PANCREATITIS ACUTE 54
611 DRY EYE 53
612 ELECTROCARDIOGRAM ABNORMAL 53
613 DRUG RESISTANCE 52
614 DRUG WITHDRAWAL SYNDROME NEONATAL 52
615 HOT FLUSH 52
616 INJECTION SITE BRUISING 52
617 LEUKAEMIA 52
618 TACHYPNOEA 52
619 COORDINATION ABNORMAL 51
620 FEAR 51
621 PERICARDIAL EFFUSION 51
622 ATAXIA 50
623 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50
624 ERECTILE DYSFUNCTION 50
625 PARALYSIS 50
626 RENAL FAILURE ACUTE 50
627 DISEASE PROGRESSION 49
628 HYPERTHYROIDISM 49
629 MULTIPLE DRUG OVERDOSE INTENTIONAL 49
630 PREMATURE BABY 49
631 SKIN LESION 49
632 ABNORMAL WEIGHT GAIN 48
633 DECREASED ACTIVITY 48
634 MULTIPLE SCLEROSIS RELAPSE 48
635 POLYDIPSIA 48
636 VENTRICULAR TACHYCARDIA 48
637 ACNE 47
638 CARDIOGENIC SHOCK 47
639 HAEMATOCHEZIA 47
640 INITIAL INSOMNIA 47
641 ACUTE RESPIRATORY FAILURE 46
642 ANAPHYLACTIC REACTION 46
643 APNOEA 46
644 BLOOD ALKALINE PHOSPHATASE INCREASED 46
645 BLOOD PRESSURE DIASTOLIC DECREASED 46
646 FACE OEDEMA 46
647 PRODUCT DISPENSING ERROR 46
648 PULMONARY CONGESTION 46
649 BLOOD LACTIC ACID INCREASED 45
650 EMPHYSEMA 45
651 HEART RATE IRREGULAR 45
652 JAUNDICE 45
653 NEUROTOXICITY 45
654 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 45
655 RIB FRACTURE 45
656 SKIN LACERATION 45
657 CATARACT 44
658 DEVICE ISSUE 44
659 GRANULOCYTOPENIA 44
660 IMPULSE-CONTROL DISORDER 44
661 PRODUCT PRESCRIBING ERROR 44
662 ACCIDENTAL POISONING 43
663 ANAL INCONTINENCE 43
664 ANGIOEDEMA 43
665 BEHAVIOUR DISORDER 43
666 BLOOD PRESSURE DIASTOLIC ABNORMAL 43
667 FEBRILE NEUTROPENIA 43
668 FOOT FRACTURE 43
669 INFUSION SITE PAIN 43
670 LIVER FUNCTION TEST ABNORMAL 43
671 MENSTRUAL DISORDER 43
672 PRODUCT DOSE OMISSION 43
673 THROAT IRRITATION 43
674 ACCIDENT 42
675 ACCIDENTAL EXPOSURE TO PRODUCT 42
676 CHOKING 42
677 DYSPHONIA 42
678 EOSINOPHILIA 42
679 HYPERTRIGLYCERIDAEMIA 42
680 HYPOTONIA 42
681 INTERNATIONAL NORMALISED RATIO INCREASED 42
682 LABELLED DRUG-DRUG INTERACTION ISSUE 42
683 LOGORRHOEA 42
684 ONYCHOMYCOSIS 42
685 PAROSMIA 42
686 WOUND COMPLICATION 42
687 GASTRITIS 41
688 MULTIPLE SCLEROSIS 41
689 ALCOHOL ABUSE 40
690 ANXIETY DISORDER 40
691 DEREALISATION 40
692 DRUG ERUPTION 40
693 HYPERAMMONAEMIA 40
694 RENAL INJURY 40
695 ANKLE FRACTURE 39
696 ANTIPSYCHOTIC DRUG LEVEL INCREASED 39
697 ASCITES 39
698 BLOOD GLUCOSE FLUCTUATION 39
699 COLITIS ISCHAEMIC 39
700 FLATULENCE 39
701 HERPES ZOSTER 39
702 IMPAIRED GASTRIC EMPTYING 39
703 INJECTION SITE HAEMORRHAGE 39
704 RESPIRATORY DISTRESS 39
705 STUPOR 39
706 VITAMIN D DECREASED 39
707 CARDIOVASCULAR DISORDER 38
708 CEREBRAL HAEMORRHAGE 38
709 CLONUS 38
710 HYPOAESTHESIA ORAL 38
711 MUSCLE SPASTICITY 38
712 NEURALGIA 38
713 NEUROLOGICAL SYMPTOM 38
714 POST-TRAUMATIC STRESS DISORDER 38
715 SCRATCH 38
716 SKIN BURNING SENSATION 38
717 TRANSIENT ISCHAEMIC ATTACK 38
718 BREAST CANCER STAGE I 37
719 CONCUSSION 37
720 CORONARY ARTERY DISEASE 37
721 DRUG LEVEL ABOVE THERAPEUTIC 37
722 DRUG LEVEL DECREASED 37
723 LOSS OF LIBIDO 37
724 MULTIPLE DRUG THERAPY 37
725 OVERWEIGHT 37
726 POOR VENOUS ACCESS 37
727 PSYCHOTIC SYMPTOM 37
728 SINUS BRADYCARDIA 37
729 SKIN DISORDER 37
730 SUDDEN DEATH 37
731 SUSPECTED OFF LABEL USE 37
732 WRONG PRODUCT ADMINISTERED 37
733 BLOOD POTASSIUM DECREASED 36
734 BODY TEMPERATURE DECREASED 36
735 DECREASED INTEREST 36
736 ENURESIS 36
737 FEELING OF DESPAIR 36
738 HAEMATOMA 36
739 MOTOR DYSFUNCTION 36
740 MUSCLE DISORDER 36
741 POLYURIA 36
742 POTENTIATING DRUG INTERACTION 36
743 TOOTH ABSCESS 36
744 VENTRICULAR ARRHYTHMIA 36
745 ARTERIOSCLEROSIS CORONARY ARTERY 35
746 ELECTROLYTE IMBALANCE 35
747 END STAGE RENAL DISEASE 35
748 OCULAR DISCOMFORT 35
749 REBOUND EFFECT 35
750 SLOW SPEECH 35
751 SOCIAL AVOIDANT BEHAVIOUR 35
752 APRAXIA 34
753 DIPLOPIA 34
754 DISCOLOURED VOMIT 34
755 DYSGEUSIA 34
756 ECONOMIC PROBLEM 34
757 HEAD DISCOMFORT 34
758 SCREAMING 34
759 SLEEP-RELATED EATING DISORDER 34
760 ACIDOSIS 33
761 BLOOD CHOLESTEROL ABNORMAL 33
762 BLOOD UREA INCREASED 33
763 DEVICE DISLOCATION 33
764 FEELING OF BODY TEMPERATURE CHANGE 33
765 HYPERTENSIVE CRISIS 33
766 INTENTIONAL DOSE OMISSION 33
767 SENSORY LOSS 33
768 SUICIDAL BEHAVIOUR 33
769 SURGERY 33
770 THERAPY INTERRUPTED 33
771 BLINDNESS 32
772 BONE PAIN 32
773 HAEMORRHOIDS 32
774 HYPOMAGNESAEMIA 32
775 INCOHERENT 32
776 INCORRECT PRODUCT ADMINISTRATION DURATION 32
777 INJECTION SITE REACTION 32
778 JOINT INJURY 32
779 LYMPHADENOPATHY 32
780 NEPHROLITHIASIS 32
781 ORAL HERPES 32
782 PHOTOSENSITIVITY REACTION 32
783 PREMATURE LABOUR 32
784 RED BLOOD CELL COUNT DECREASED 32
785 RHINITIS 32
786 SLUGGISHNESS 32
787 THROAT TIGHTNESS 32
788 TOXIC EPIDERMAL NECROLYSIS 32
789 ACUTE HEPATIC FAILURE 31
790 DECUBITUS ULCER 31
791 DEPERSONALISATION/DEREALISATION DISORDER 31
792 DIABETES INSIPIDUS 31
793 DISORGANISED SPEECH 31
794 EYE SWELLING 31
795 FULL BLOOD COUNT ABNORMAL 31
796 GASTRIC PH DECREASED 31
797 IMPAIRED WORK ABILITY 31
798 NEUTROPHIL COUNT INCREASED 31
799 PAIN IN JAW 31
800 PRODUCT LABEL CONFUSION 31
801 ACUTE PULMONARY OEDEMA 30
802 AFFECT LABILITY 30
803 ALCOHOL POISONING 30
804 BRAIN HERNIATION 30
805 CONJUNCTIVITIS 30
806 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 30
807 FRACTURE 30
808 HAEMATEMESIS 30
809 HYPERTONIA 30
810 INJECTION SITE ERYTHEMA 30
811 INJECTION SITE INFLAMMATION 30
812 MUSCULOSKELETAL CHEST PAIN 30
813 PANIC REACTION 30
814 RASH MACULO-PAPULAR 30
815 SEASONAL ALLERGY 30
816 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 30
817 BLOOD GLUCOSE ABNORMAL 29
818 BLOOD GLUCOSE DECREASED 29
819 DRUG EXPOSURE DURING PREGNANCY 29
820 HAEMODYNAMIC INSTABILITY 29
821 HEART RATE ABNORMAL 29
822 ILEUS 29
823 LIP SWELLING 29
824 MOUTH ULCERATION 29
825 SKIN CANCER 29
826 THERAPY CESSATION 29
827 ACUTE PSYCHOSIS 28
828 ATRIAL SEPTAL DEFECT 28
829 BLOOD PRESSURE DIASTOLIC INCREASED 28
830 CARDIOMEGALY 28
831 DEVICE OCCLUSION 28
832 DRUG SCREEN POSITIVE 28
833 HOMICIDAL IDEATION 28
834 HUNGER 28
835 ISCHAEMIC CEREBRAL INFARCTION 28
836 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28
837 LEFT VENTRICULAR FAILURE 28
838 MATERNAL DRUGS AFFECTING FOETUS 28
839 MICTURITION URGENCY 28
840 MONOCYTE COUNT INCREASED 28
841 OCULAR HYPERAEMIA 28
842 PARADOXICAL DRUG REACTION 28
843 RASH MACULAR 28
844 RESPIRATORY ACIDOSIS 28
845 TOOTH DISORDER 28
846 WRONG PATIENT RECEIVED PRODUCT 28
847 BIPOLAR I DISORDER 27
848 BRUXISM 27
849 CHOLESTASIS 27
850 DRUG DIVERSION 27
851 FAECES DISCOLOURED 27
852 FOOD CRAVING 27
853 GAZE PALSY 27
854 HYPERNATRAEMIA 27
855 HYPERPHAGIA 27
856 IMPULSIVE BEHAVIOUR 27
857 INTENTIONAL MISUSE 27
858 INTERVERTEBRAL DISC PROTRUSION 27
859 LOCALISED INFECTION 27
860 MYOCARDIAL ISCHAEMIA 27
861 NOCTURIA 27
862 PAIN OF SKIN 27
863 PHOTOPHOBIA 27
864 PUPILLARY REFLEX IMPAIRED 27
865 SELF-INJURIOUS IDEATION 27
866 SENSATION OF FOREIGN BODY 27
867 TENSION 27
868 TERMINAL INSOMNIA 27
869 TIC 27
870 UPPER-AIRWAY COUGH SYNDROME 27
871 VASOPLEGIA SYNDROME 27
872 VENTRICULAR EXTRASYSTOLES 27
873 ACCIDENTAL DEATH 26
874 ADVERSE REACTION 26
875 BEDRIDDEN 26
876 BLOOD URINE PRESENT 26
877 BRAIN FOG 26
878 BUNDLE BRANCH BLOCK RIGHT 26
879 CARDIOTOXICITY 26
880 CORONARY ARTERY STENOSIS 26
881 EOSINOPHIL COUNT DECREASED 26
882 FORCED EXPIRATORY VOLUME DECREASED 26
883 GASTRIC DISORDER 26
884 H1N1 INFLUENZA 26
885 HEPATITIS ACUTE 26
886 HEREDITARY ANGIOEDEMA 26
887 HOSPICE CARE 26
888 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26
889 INTERSTITIAL LUNG DISEASE 26
890 NEOPLASM MALIGNANT 26
891 PERSONALITY DISORDER 26
892 PHARYNGITIS 26
893 PRODUCT ADMINISTRATION INTERRUPTED 26
894 PRODUCT DOSE OMISSION IN ERROR 26
895 RESTRICTIVE PULMONARY DISEASE 26
896 SECRETION DISCHARGE 26
897 SKIN HAEMORRHAGE 26
898 SUBDURAL HAEMATOMA 26
899 TRISMUS 26
900 VISUAL ACUITY REDUCED 26
901 ANKYLOSING SPONDYLITIS 25
902 ASPHYXIA 25
903 BLADDER PROLAPSE 25
904 BUNDLE BRANCH BLOCK LEFT 25
905 CLEFT PALATE 25
906 RESPIRATORY RATE DECREASED 25
907 STEVENS-JOHNSON SYNDROME 25
908 TOOTHACHE 25
909 AREFLEXIA 24
910 AUTONOMIC NERVOUS SYSTEM IMBALANCE 24
911 BRADYPNOEA 24
912 DERMATITIS CONTACT 24
913 DYSPHEMIA 24
914 EXTRA DOSE ADMINISTERED 24
915 HYPOACUSIS 24
916 ILEUS PARALYTIC 24
917 IMMUNE SYSTEM DISORDER 24
918 NASAL DISCHARGE DISCOLOURATION 24
919 RECTAL PROLAPSE 24
920 REFUSAL OF TREATMENT BY PATIENT 24
921 RENAL TUBULAR NECROSIS 24
922 SENSORY DISTURBANCE 24
923 STARING 24
924 TALIPES 24
925 TENDER JOINT COUNT 24
926 THERAPEUTIC PRODUCT INEFFECTIVE 24
927 TONGUE DISORDER 24
928 ACUTE MYOCARDIAL INFARCTION 23
929 BLOOD PRESSURE ABNORMAL 23
930 BONE DENSITY DECREASED 23
931 COLITIS 23
932 COMMUNICATION DISORDER 23
933 DRUG ABUSER 23
934 EOSINOPHIL COUNT ABNORMAL 23
935 EYE DISORDER 23
936 GYNAECOMASTIA 23
937 HYPERCAPNIA 23
938 INJECTION SITE SWELLING 23
939 JOINT EFFUSION 23
940 LEFT VENTRICULAR DYSFUNCTION 23
941 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 23
942 PNEUMOCOCCAL INFECTION 23
943 PROTEIN TOTAL INCREASED 23
944 PULSELESS ELECTRICAL ACTIVITY 23
945 SMALL FOR DATES BABY 23
946 SOMATIC SYMPTOM DISORDER 23
947 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22
948 ACTIVITIES OF DAILY LIVING IMPAIRED 22
949 ANURIA 22
950 BLOOD ALBUMIN DECREASED 22
951 BLOOD PRESSURE SYSTOLIC DECREASED 22
952 CEREBRAL DISORDER 22
953 DEMENTIA ALZHEIMER^S TYPE 22
954 DRUG EFFECT DECREASED 22
955 ELECTRIC SHOCK 22
956 GASTRIC INFECTION 22
957 HEAD TITUBATION 22
958 HEPATIC ENCEPHALOPATHY 22
959 INTERNAL HAEMORRHAGE 22
960 LACRIMATION INCREASED 22
961 LOW BIRTH WEIGHT BABY 22
962 MELAENA 22
963 MULTI-ORGAN FAILURE 22
964 PULMONARY THROMBOSIS 22
965 SUPRAVENTRICULAR TACHYCARDIA 22
966 THROMBOTIC THROMBOCYTOPENIC PURPURA 22
967 TOOTH LOSS 22
968 TUBULOINTERSTITIAL NEPHRITIS 22
969 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 21
970 CANDIDA INFECTION 21
971 DEFORMITY 21
972 DERMATITIS ALLERGIC 21
973 DRUG SCREEN FALSE POSITIVE 21
974 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 21
975 ELECTROENCEPHALOGRAM ABNORMAL 21
976 EXCESSIVE EYE BLINKING 21
977 HEMIPARESIS 21
978 INFUSION SITE ERYTHEMA 21
979 INJECTION SITE MASS 21
980 INJECTION SITE PRURITUS 21
981 INTESTINAL HAEMORRHAGE 21
982 LONG QT SYNDROME 21
983 LUNG NEOPLASM 21
984 MASS 21
985 MEAN CELL HAEMOGLOBIN DECREASED 21
986 NEEDLE ISSUE 21
987 NYSTAGMUS 21
988 ORAL CANDIDIASIS 21
989 ORAL DISCOMFORT 21
990 OROMANDIBULAR DYSTONIA 21
991 OSTEOPENIA 21
992 PARKINSON^S DISEASE PSYCHOSIS 21
993 PLEUROTHOTONUS 21
994 RESPIRATORY RATE INCREASED 21
995 RESPIRATORY TRACT CONGESTION 21
996 SYMPTOM RECURRENCE 21
997 TACHYPHRENIA 21
998 UPPER LIMB FRACTURE 21
999 VIRAL INFECTION 21